Table 2.

Results from pair-wise comparisons for each outcome measure at baseline and the 4-, 8-, and 12- week examinations, by treatment group.

Treatment group	Baseline to Week 4		Week 4 to Week 8		Week 8 to Week 12
	Change	p-value†	Change	p-value†	Change	p-value†
	CI Symptom Survey score
HBPP	2.3	0.045	0.5	0.95	3.6	<0.001
HBCVAT+	1.9	0.11	2.9	0.007	1.9	0.038
OBVAT	4.5	<0.001	4.4	<0.001	5.8	<0.001
OBPT	2.0	0.10	2.9	0.007	3.0	<0.001
	Near point of convergence break (cm)
HBPP	4.4	<0.001	1.8	0.030	0.7	0.69
HBCVAT+	4.4	<0.001	1.8	0.031	1.5	0.025
OBVAT	6.5	<0.001	1.7	0.020	1.3	0.024
OBPT	2.3	0.062	1.1	0.27	0.6	0.60
	Positive fusional vergence (Δ)
HBPP	4.1	0.004	1.9	0.37	1.9	0.26
HBCVAT+	8.9	<0.001	1.8	0.37	1.5	0.46
OBVAT	11.2	<0.001	4.5	<0.001	3.6	0.002
OBPT	3.9	0.005	2.2	0.19	0.8	0.87

^†Adjusted for multiple comparisons